Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa

Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa

Abstract Background Multi-drug resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) in pregnant women is a cause for concern globally; few data have described the safety of second-line anti-TB medications during pregnancy. We aim to describe TB treatment and pregnancy outcomes among pregnant...

Full description

Bibliographic Details
Main Authors: Idah Mokhele, Nelly Jinga, Rebecca Berhanu, Thandi Dlamini, Lawrence Long, Denise Evans
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Pregnancy and Childbirth
Subjects:
Multi-drug-resistant tuberculosis
Rifampicin resistance
South Africa
Pregnancy
HIV
Second-line anti-TB treatment
Online Access:https://doi.org/10.1186/s12884-021-03956-6

Internet

https://doi.org/10.1186/s12884-021-03956-6

Similar Items